With Dr. Konstanze Diefenbach, the head of Radiology Research & Development at Bayer, we will discuss the latest advancements in contrast media and healthcare AI. Dr. Diefenbach will share key findings from the Phase III trials of the investigational MR contrast agent gadoquatrane. Also we will jointly take a glimpse into the future of AI in radiology and delve into the company's collaboration with Google Cloud and the development of the Bayer’s AI Innovation Platform, addressing the need for innovative solutions in healthcare AI.
Interview
Konstanze Diefenbach, Berlin / Germany